Skip to main content

HighVista Strategies LLC

13F filer · CIK 0001335325
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$439MU.S. long equity reported on 13F
Positions14729 new · 38 closed
Net flow last quarter-$2.25MBuys minus sells
Top 10 positions weight28.2%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 2026147 positions
DBCInvesco DB Commodity Index Tracking Fund$28.2M6.43%1.78%Not reportedQ4 2018
ABVXAbivax S.A.$15.1M3.43%0.14%-0.2%Q1 2024
RVMDRevolution Medicines, Inc.$12.5M2.86%0.03%-3.4%Q1 2021
DFTXDefinium Therapeutics, Inc.$11.4M2.60%0.18%+30.7%Q1 2026
IMVTImmunovant, Inc.$10.7M2.44%0.13%+23.4%Q3 2020
PRAXPraxis Precision Medicines, Inc.$10.1M2.31%0.11%+14.8%Q3 2024
RLAYRelay Therapeutics, Inc.$9.47M2.16%0.23%+20.0%Q4 2020
ALKSAlkermes plc.$9.39M2.14%0.11%+144.9%Q4 2024
PCVXVaxcyte, Inc.$8.7M1.98%0.10%+20.1%Q2 2022
TNGXTango Therapeutics, Inc.$8.13M1.85%0.15%+149.6%Q1 2026
LQDALiquidia Corp$7.81M1.78%0.11%-1.9%Q2 2024
COGTCogent Biosciences, Inc.$7.31M1.67%0.11%-4.2%Q3 2022
GPCRStructure Therapeutics Inc.$7.02M1.60%0.06%+5.6%Q3 2023
ELVNEnliven Therapeutics, Inc.$7M1.60%0.19%+88.6%Q2 2023
AMLXAmylyx Pharmaceuticals, Inc.$6.93M1.58%0.35%+9.7%Q2 2023
SYRESpyre Therapeutics, Inc.$6.91M1.57%0.09%-46.8%Q4 2023
LBRXLB Pharmaceuticals Inc$6.86M1.57%0.74%+21.8%Q4 2025
CYTKCytokinetics Inc$6.65M1.52%0.06%+33.0%Q4 2020
CCCCC4 Therapeutics, Inc.$6.3M1.44%1.10%Not reportedQ1 2021
TYRATyra Biosciences, Inc.$5.9M1.35%0.31%+40.7%Q2 2024
ALMSAlumis Inc.$5.63M1.28%Not reported+77.1%Q1 2026
PHVSPharvaris N.V.$5.55M1.27%0.25%+64.0%Q1 2024
TARSTarsus Pharmaceuticals, Inc.$5.48M1.25%0.20%+65.9%Q1 2021
CMPSCOMPASS Pathways plc$5.25M1.20%0.27%+1.9%Q4 2025
DNTHDianthus Therapeutics, Inc.$4.98M1.14%0.09%+43.7%Q3 2024
NRIXNurix Therapeutics, Inc.$4.94M1.13%0.20%-10.1%Q1 2021
AXSMAxsome Therapeutics, Inc.$4.94M1.13%0.04%-1.2%Q2 2020
TVTXTravere Therapeutics, Inc.$4.9M1.12%0.09%+137.4%Q1 2021
VERAVera Therapeutics, Inc.$4.54M1.04%0.15%+53.0%Q3 2023
NVDANvidia Corp$4.36M0.99%0.00%-2.8%Q2 2024
GHRSGH Research PLC$4.27M0.97%0.26%-25.5%Q4 2021
PALIPalisade Bio, Inc.$4.24M0.97%1.17%+0.6%Q4 2025
ARGXArgenx SE$4.23M0.96%0.01%-7.3%Q2 2020
MAZEMaze Therapeutics, Inc.$4.08M0.93%0.25%+36.8%Q4 2025
OCULOcular Therapeutix, Inc$4.01M0.91%0.19%-7.5%Q2 2021
ORKAOruka Therapeutics, Inc.$3.99M0.91%0.07%-46.9%Q1 2026
DYNDyne Therapeutics, Inc.$3.82M0.87%0.10%-6.0%Q4 2020
EWTXEdgewise Therapeutics, Inc.$3.7M0.84%0.08%-1.0%Q2 2021
MLTXMoonLake Immunotherapeutics$3.66M0.83%0.26%-3.1%Q1 2023
INSMINSMED Inc$3.33M0.76%0.01%+28.5%Q2 2020
CLDXCelldex Therapeutics, Inc.$3.24M0.74%0.11%-2.7%Q3 2020
AMZNAmazon Com Inc$3.19M0.73%0.00%-40.2%Q1 2016
IVAInventiva S.A.$3.14M0.72%0.43%+35.1%Q1 2026
TLNTalen Energy Corp$3.13M0.71%0.02%+161.3%Q4 2024
RLMDRelmada Therapeutics, Inc.$3.08M0.70%0.42%Not reportedQ2 2020
PTGXProtagonist Therapeutics, Inc$3M0.68%0.04%-27.7%Q2 2021
ERASErasca, Inc.$2.94M0.67%0.05%-11.5%Q4 2024
VRDNViridian Therapeutics, Inc.\DE$2.94M0.67%0.14%+19.1%Q1 2022
HPEHewlett Packard Enterprise Co$2.67M0.61%0.00%-34.3%Q2 2016
MLYSMineralys Therapeutics, Inc.$2.32M0.53%0.10%+84.0%Q2 2025
Q1 2026Reported May 15, 2026156 positions
DBCInvesco DB Commodity Index Tracking Fund$30.6M8.45%1.81%Not reportedQ4 2018
ABVXAbivax S.A.$12.6M3.48%0.14%+56.9%Q1 2024
PRAXPraxis Precision Medicines, Inc.$8.48M2.34%0.09%+1.9%Q3 2024
COGTCogent Biosciences, Inc.$7.58M2.09%0.12%-41.5%Q3 2022
SYRESpyre Therapeutics, Inc.$7.38M2.04%0.19%-22.3%Q4 2023
PCVXVaxcyte, Inc.$7.24M2.00%0.09%+9.3%Q2 2022
RVMDRevolution Medicines, Inc.$6.74M1.86%0.03%-42.4%Q1 2021
TERNTerns Pharmaceuticals, Inc.$6.03M1.66%0.10%-34.9%Q3 2022
GPCRStructure Therapeutics Inc.$5.97M1.65%0.06%-35.8%Q3 2023
NUVLNuvalent, Inc.$5.8M1.60%1.81%-22.8%Q1 2023
IMVTImmunovant, Inc.$5.59M1.54%0.11%+1.5%Q3 2020
SLNOSoleno Therapeutics Inc$5.53M1.53%0.32%+22.3%Q1 2024
TYRATyra Biosciences, Inc.$5.03M1.39%0.22%+274.2%Q2 2024
AMLXAmylyx Pharmaceuticals, Inc.$4.89M1.35%0.32%+47.4%Q2 2023
AMZNAmazon Com Inc$4.66M1.29%0.00%+28.7%Q1 2016
LBRXLB Pharmaceuticals Inc$4.28M1.18%0.61%+23.9%Q4 2025
RLAYRelay Therapeutics, Inc.$4.2M1.16%0.22%-22.6%Q4 2020
INSMINSMED Inc$3.98M1.10%0.01%-38.3%Q2 2020
NVDANvidia Corp$3.91M1.08%0.00%+57.7%Q2 2024
ORKAOruka Therapeutics, Inc.$3.87M1.07%0.16%NewQ1 2026
CYTKCytokinetics Inc$3.87M1.07%0.05%-48.8%Q4 2020
LQDALiquidia Corp$3.76M1.04%0.11%-36.1%Q2 2024
OCULOcular Therapeutix, Inc$3.74M1.03%0.20%+28.3%Q2 2021
TARSTarsus Pharmaceuticals, Inc.$3.68M1.02%0.12%-2.1%Q1 2021
BBIOBridgeBio Pharma, Inc.$3.68M1.02%0.03%-38.2%Q2 2021
MLTXMoonLake Immunotherapeutics$3.62M1.00%0.37%Not reportedQ1 2023
ARGXArgenx SE$3.59M0.99%0.01%+37.1%Q2 2020
PTGXProtagonist Therapeutics, Inc$3.57M0.99%0.05%-54.0%Q2 2021
PALIPalisade Bio, Inc.$3.53M0.98%1.21%+55.3%Q4 2025
DFTXDefinium Therapeutics, Inc.$3.51M0.97%0.18%NewQ1 2026
NRIXNurix Therapeutics, Inc.$3.51M0.97%0.22%Not reportedQ1 2021
AXSMAxsome Therapeutics, Inc.$3.45M0.95%0.04%+83.6%Q2 2020
IVAInventiva S.A.$3.42M0.94%0.32%NewQ1 2026
DYNDyne Therapeutics, Inc.$3.32M0.92%0.11%+206.7%Q4 2020
APGEApogee Therapeutics, Inc.$3.01M0.83%0.05%-59.9%Q1 2024
GHRSGH Research PLC$3M0.83%0.34%-11.4%Q4 2021
DNTHDianthus Therapeutics, Inc.$2.99M0.82%0.07%-26.6%Q3 2024
MAZEMaze Therapeutics, Inc.$2.98M0.82%0.20%-41.4%Q4 2025
ERASErasca, Inc.$2.93M0.81%0.06%Not reportedQ4 2024
EWTXEdgewise Therapeutics, Inc.$2.9M0.80%0.09%-46.3%Q2 2021
ELVNEnliven Therapeutics, Inc.$2.87M0.79%0.12%-11.4%Q2 2023
XENEXenon Pharmaceuticals Inc.$2.85M0.79%0.05%Not reportedQ2 2020
CLDXCelldex Therapeutics, Inc.$2.84M0.78%0.13%+72.6%Q3 2020
VERAVera Therapeutics, Inc.$2.79M0.77%0.11%Not reportedQ3 2023
PHVSPharvaris N.V.$2.76M0.76%0.15%-39.7%Q1 2024
VRDNViridian Therapeutics, Inc.\DE$2.63M0.72%0.13%-64.0%Q1 2022
ALKSAlkermes plc.$2.59M0.71%0.04%+177.2%Q4 2024
ALMSAlumis Inc.$2.49M0.69%Not reportedNewQ1 2026
MSFTMicrosoft Corp$2.39M0.66%0.00%-1.2%Q2 2013
EYPTEyePoint, Inc.$2.36M0.65%0.22%NewQ1 2026
Q4 2025Reported Feb 17, 2026145 positions
DBCInvesco DB Commodity Index Tracking Fund$23.6M6.09%1.84%-26.4%Q4 2018
GPCRStructure Therapeutics Inc.$13.4M3.46%0.09%-18.3%Q3 2023
COGTCogent Biosciences, Inc.$12M3.08%0.21%-27.2%Q3 2022
VRDNViridian Therapeutics, Inc.\DE$11.6M2.99%0.37%-20.6%Q1 2022
ABVXAbivax S.A.$9.73M2.51%0.09%-60.9%Q1 2024
RVMDRevolution Medicines, Inc.$9.58M2.47%0.06%-31.5%Q1 2021
PRAXPraxis Precision Medicines, Inc.$7.62M1.96%0.10%-72.8%Q3 2024
NUVLNuvalent, Inc.$7.37M1.90%2.34%-21.5%Q1 2023
CYTKCytokinetics Inc$7.28M1.87%0.09%-13.8%Q4 2020
TERNTerns Pharmaceuticals, Inc.$7.09M1.83%0.16%Not reportedQ3 2022
MAZEMaze Therapeutics, Inc.$7.06M1.82%0.35%NewQ4 2025
INSMINSMED Inc$6.86M1.77%0.02%-21.1%Q2 2020
APGEApogee Therapeutics, Inc.$6.74M1.73%0.13%-16.7%Q1 2024
PTGXProtagonist Therapeutics, Inc$6.42M1.65%0.12%-39.6%Q2 2021
SLNOSoleno Therapeutics Inc$6.25M1.61%0.26%+622.3%Q1 2024
SYRESpyre Therapeutics, Inc.$6.17M1.59%0.24%-12.8%Q4 2023
BBIOBridgeBio Pharma, Inc.$6.13M1.58%0.04%-2.1%Q2 2021
OLMAOlema Pharmaceuticals, Inc.$6.04M1.55%0.30%-44.8%Q1 2021
IMVTImmunovant, Inc.$5.64M1.45%0.11%-12.3%Q3 2020
LQDALiquidia Corp$5.38M1.39%0.18%-11.6%Q2 2024
PCVXVaxcyte, Inc.$5.26M1.36%0.09%+31.4%Q2 2022
CDTXCidara Therapeutics, Inc.$5.06M1.30%0.07%-67.7%Q3 2020
ACLXArcellx, Inc.$4.89M1.26%0.13%-22.0%Q1 2023
RLAYRelay Therapeutics, Inc.$4.61M1.19%0.31%+126.7%Q4 2020
RYTMRhythm Pharmaceuticals, Inc.$4.59M1.18%0.06%+14.4%Q2 2020
MLYSMineralys Therapeutics, Inc.$4.52M1.16%0.15%-40.7%Q2 2025
PHVSPharvaris N.V.$4.51M1.16%0.25%Not reportedQ1 2024
TARSTarsus Pharmaceuticals, Inc.$4.39M1.13%0.13%+115.5%Q1 2021
EWTXEdgewise Therapeutics, Inc.$4.25M1.09%0.16%-17.8%Q2 2021
OCULOcular Therapeutix, Inc$4.18M1.08%0.16%+222.7%Q2 2021
AGIOAgios Pharmaceuticals, Inc.$4.02M1.04%0.25%-24.4%Q1 2025
AMZNAmazon Com Inc$4.02M1.03%0.00%-34.1%Q1 2016
APLSApellis Pharmaceuticals, Inc.$3.79M0.98%0.12%+3.5%Q3 2021
GHGuardant Health, Inc.$3.75M0.97%0.03%-43.1%Q4 2024
STOKStoke Therapeutics, Inc.$3.67M0.94%0.20%Not reportedQ2 2020
CMPSCOMPASS Pathways plc$3.44M0.89%0.52%NewQ4 2025
MSFTMicrosoft Corp$3.16M0.81%0.00%-30.9%Q2 2013
LBRXLB Pharmaceuticals Inc$3.12M0.80%0.55%NewQ4 2025
PALIPalisade Bio, Inc.$3.06M0.79%0.82%NewQ4 2025
GHRSGH Research PLC$3.05M0.79%0.39%-0.6%Q4 2021
ARGXArgenx SE$3.02M0.78%0.01%-11.8%Q2 2020
XOMAXOMA Royalty Corp$3M0.77%0.95%+6.8%Q1 2023
TDGTransDigm Group INC$2.89M0.74%0.00%Not reportedQ2 2013
RNAMAvidity Biosciences, Inc.$2.89M0.74%0.03%-39.0%Q3 2020
AMLXAmylyx Pharmaceuticals, Inc.$2.88M0.74%0.22%Not reportedQ2 2023
BBOTBridgeBio Oncology Therapeutics, Inc.$2.87M0.74%0.29%NewQ4 2025
NVDANvidia Corp$2.65M0.68%0.00%+6.1%Q2 2024
CRMSalesforce, Inc.$2.28M0.59%0.00%-33.2%Q2 2022
VVisa Inc.$2.21M0.57%0.00%-20.0%Q2 2013
SEPNSepterna, Inc.$2.19M0.56%0.18%NewQ4 2025
Q3 2025Reported Nov 14, 2025148 positions
DBCInvesco DB Commodity Index Tracking Fund$32.4M7.93%2.50%Not reportedQ4 2018
ABVXAbivax S.A.$15.7M3.84%0.29%+260.6%Q1 2024
MRUSMerus N.V.$12.6M3.08%0.18%+48.5%Q4 2021
VRDNViridian Therapeutics, Inc.\DE$10.1M2.48%0.57%-3.1%Q1 2022
RVMDRevolution Medicines, Inc.$8.19M2.01%0.09%+157.8%Q1 2021
PTGXProtagonist Therapeutics, Inc$8.08M1.98%0.19%+110.3%Q2 2021
NUVLNuvalent, Inc.$8.07M1.98%2.98%+84.9%Q1 2023
MLYSMineralys Therapeutics, Inc.$7.96M1.95%0.27%+39.8%Q2 2025
ACLXArcellx, Inc.$7.9M1.94%0.17%+169.3%Q1 2023
AGIOAgios Pharmaceuticals, Inc.$7.84M1.92%0.34%+178.5%Q1 2025
CYTKCytokinetics Inc$7.31M1.79%0.11%+93.6%Q4 2020
INSMINSMED Inc$7.19M1.76%0.02%+330.8%Q2 2020
CDTXCidara Therapeutics, Inc.$6.79M1.66%0.24%Not reportedQ3 2020
COGTCogent Biosciences, Inc.$6.64M1.63%0.33%+63.3%Q3 2022
GPCRStructure Therapeutics Inc.$6.61M1.62%0.13%+172.7%Q3 2023
AMZNAmazon Com Inc$5.8M1.42%0.00%+39.7%Q1 2016
SNDKSandisk Corp$5.32M1.31%0.03%+19.8%Q1 2016
ELVNEnliven Therapeutics, Inc.$5.3M1.30%0.44%+83.1%Q2 2023
AKROAkero Therapeutics, Inc.$5.23M1.28%0.14%+83.5%Q4 2020
PRAXPraxis Precision Medicines, Inc.$5.04M1.23%0.45%+41.2%Q3 2024
MSFTMicrosoft Corp$4.9M1.20%0.00%-7.8%Q2 2013
OLMAOlema Pharmaceuticals, Inc.$4.28M1.05%0.64%+57.0%Q1 2021
BBIOBridgeBio Pharma, Inc.$4.26M1.04%0.04%+21.4%Q2 2021
APGEApogee Therapeutics, Inc.$4.26M1.04%0.18%+137.7%Q1 2024
IMVTImmunovant, Inc.$4.08M1.00%0.15%+38.5%Q3 2020
XOMAXOMA Royalty Corp$4.07M1.00%0.86%-7.7%Q1 2023
GHGuardant Health, Inc.$4.04M0.99%0.05%+128.5%Q4 2024
LQDALiquidia Corp$4.01M0.98%0.20%+46.3%Q2 2024
RYTMRhythm Pharmaceuticals, Inc.$3.79M0.93%0.06%+33.5%Q2 2020
SYRESpyre Therapeutics, Inc.$3.62M0.89%0.36%+91.3%Q4 2023
CLDXCelldex Therapeutics, Inc.$3.5M0.86%0.20%+26.9%Q3 2020
GHRSGH Research PLC$3.46M0.85%0.46%+363.0%Q4 2021
EWTXEdgewise Therapeutics, Inc.$3.38M0.83%0.20%+198.5%Q2 2021
AVGOBroadcom Inc.$3.37M0.82%0.00%-20.3%Q3 2017
METAMeta Platforms, Inc.$3.3M0.81%Not reported+45.2%Q1 2014
XENEXenon Pharmaceuticals Inc.$3.3M0.81%0.11%+80.2%Q2 2020
APLSApellis Pharmaceuticals, Inc.$3.3M0.81%0.12%+68.2%Q3 2021
PCVXVaxcyte, Inc.$3.13M0.77%0.07%+159.4%Q2 2022
CRMSalesforce, Inc.$3.05M0.75%0.00%+15.2%Q2 2022
ARGXArgenx SE$3M0.74%0.01%+68.5%Q2 2020
RNAMAvidity Biosciences, Inc.$2.86M0.70%0.04%+60.5%Q3 2020
AMDAdvanced Micro Devices Inc$2.78M0.68%0.00%+11.7%Q1 2024
XPOXPO, Inc.$2.73M0.67%0.02%Not reportedQ2 2022
UUnity Software Inc.$2.69M0.66%0.02%+17.7%Q2 2025
VVisa Inc.$2.68M0.66%0.00%+22.3%Q2 2013
VERAVera Therapeutics, Inc.$2.65M0.65%0.14%+125.3%Q3 2023
CEGConstellation Energy Corp$2.5M0.61%0.00%-8.4%Q4 2024
NVDANvidia Corp$2.5M0.61%0.00%-14.7%Q2 2024
HPEHewlett Packard Enterprise Co$2.42M0.59%0.01%+14.5%Q2 2016
MAMastercard Inc$2.39M0.59%0.00%+5.1%Q2 2013
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.